Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using 18F-FDG positron emission tomography
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Endocrine, 53, 3, S. 791-800
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2016
- Event
-
Veröffentlichung
- (where)
-
Berlin
- (who)
-
Springer
- (when)
-
2016
- Creator
-
Wolf, Herta
Kroiss, Matthias
Nakajo, Masatoyo
Mügge, Dirk O.
Hahner, Stefanie
Faßnacht, Martin
Schirbel, Andreas
Bluemel, Christina
Higuchi, Takahiro
Papp, Laszló
Zsótér, Norbert
Buck, Andreas K.
Bundschuh, Ralph A.
Lapa, Constantin Frederik Victor
- DOI
-
10.1007/s12020-016-0970-1
- URN
-
urn:nbn:de:bvb:384-opus4-633771
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wolf, Herta
- Kroiss, Matthias
- Nakajo, Masatoyo
- Mügge, Dirk O.
- Hahner, Stefanie
- Faßnacht, Martin
- Schirbel, Andreas
- Bluemel, Christina
- Higuchi, Takahiro
- Papp, Laszló
- Zsótér, Norbert
- Buck, Andreas K.
- Bundschuh, Ralph A.
- Lapa, Constantin Frederik Victor
- Universität Augsburg
- Springer
Time of origin
- 2016
Other Objects (12)
Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma
Prognostic role of quantitative [18F]FDG PET/CT parameters in adrenocortical carcinoma
Radiopharmaceuticals for treatment of adrenocortical carcinoma
Kyriotop - "Personale Formation von Religion" bei Paulus
CXCR4-targeted theranostics in oncology
CXCR4-targeted theranostics in oncology
Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Investigating the chemokine receptor 4 as potential theranostic target in adrenocortical cancer patients
Novel CYP11B-ligand [\(^123/131}\)I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Molekulare Bildgebung der Proliferation in vivo mit Positronen-Emissions-Tomographie
The role of molecular profiling in adrenocortical carcinoma
Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma
Prognostic role of quantitative [18F]FDG PET/CT parameters in adrenocortical carcinoma
Radiopharmaceuticals for treatment of adrenocortical carcinoma
Kyriotop - "Personale Formation von Religion" bei Paulus
CXCR4-targeted theranostics in oncology
CXCR4-targeted theranostics in oncology
Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Investigating the chemokine receptor 4 as potential theranostic target in adrenocortical cancer patients
Novel CYP11B-ligand [\(^123/131}\)I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Molekulare Bildgebung der Proliferation in vivo mit Positronen-Emissions-Tomographie
The role of molecular profiling in adrenocortical carcinoma
Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma
Prognostic role of quantitative [18F]FDG PET/CT parameters in adrenocortical carcinoma
Radiopharmaceuticals for treatment of adrenocortical carcinoma
Kyriotop - "Personale Formation von Religion" bei Paulus
CXCR4-targeted theranostics in oncology
CXCR4-targeted theranostics in oncology
Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Investigating the chemokine receptor 4 as potential theranostic target in adrenocortical cancer patients
Novel CYP11B-ligand [\(^123/131}\)I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Molekulare Bildgebung der Proliferation in vivo mit Positronen-Emissions-Tomographie